March 10, 2015 / 12:32 PM / in 3 years

BUZZ-U.S. STOCKS ON THE MOVE-Urban Outfitters, Qualcomm, Apple

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures fell on Tuesday, pressured by weaker-than-expected data out of China as well as ongoing concerns about debt talks in Greece. Dow Jones industrial average futures were down 1.06 percent at 17,780, S&P 500 futures were down 1.03 percent at 2,056.25 and Nasdaq 100 futures were down 0.93 percent at 4,372.25.

** APPLE INC, Monday close $127.14, -0.59 pct premarket

Apple launched its long-awaited watch on Monday, including yellow or rose gold models with sapphire faces costing up to $17,000, but some investors questioned whether Chief Executive Tim Cook’s first product would be a breakaway hit.

** URBAN OUTFITTERS INC, Monday close $39.51, +6.81 pct premarket

The apparel retailer reported a better-than-expected quarterly profit as comparable sales rose for the first time in a year, helped by a recovery at the company’s namesake brand and strong demand for its Free People line of clothes.

At least 14 brokerages, including Barclays, Credit Suisse, raised their price targets to as much as $49.

Janney Capital Markets analysts raised their rating to “buy”.

** QUALCOMM INC, Monday close $72.705, +2.81 pct premarket

The chipmaker said it would buy back up to $15 billion of shares and raise its quarterly dividend. The new buyback plan replaces the previous program, which had $2.1 billion authorization remaining, Qualcomm said.

** VALEANT PHARMACEUTICALS, Monday close $204.69, +0.15 pct premarket

Billionaire investor William Ackman has purchased a 5 percent stake in Valeant, his hedge fund said on Monday, making him the Canadian drug company’s fifth-largest stakeholder.

** BOEING CO, Monday close $154.75

Boeing pledged on Monday to improve the efficiency and seating capacity of its 777 to shore up production of its most profitable airliner before it switches to a newer model.

** GLADSTONE INVESTMENT CORP, Monday close $7.6, -2.63 pct premarket

The investment management company plans to sell 3 million shares of common stock. The offering represents 11.3 percent of total outstanding shares, as of March 9.

** EXELIS INC, Monday close $23.91, -0.25 pct premarket

The U.S. aerospace company is close to unveiling a low-altitude surveillance system for drones, the latest sign of how a “highway in the sky” is likely to evolve.

** VERISK ANALYTICS INC, Monday close $71.365

The provider of risk assessment data to the insurance industry said it would buy British energy consultancy Wood Mackenzie for 1.85 billion pounds ($2.78 billion) from buyout firm Hellman & Friedman LLC.

** PFIZER INC, Monday close $34.03, -0.68 pct premarket

The U.S. Food and Drug Administration warned on Monday that Pfizer’s quit-smoking drug, Chantix, has been associated with seizures and that some patients who drink while taking the drug may become aggressive or black out.

** MARKIT LTD, Monday close $26.02

The financial data company will acquire the Halifax House Price Index, a closely watched gauge of British house prices, from Lloyds Banking Group, the companies said in a statement on Tuesday. [ID:nS8N0T9018

** BPZ RESOURCES INC, Monday close $0.153

The Texas-based oil producer with operations in Peru filed for bankruptcy protection on Monday, becoming the latest energy company to fold amid low oil prices.

** ALIBABA GROUP HOLDING LTD, Monday close $82.53, -1.30 pct premarket

Alibaba appointed Jeff Zhang to oversee its main services on Monday, bringing Taobao, Tmall and Juhuasuan into a newly created “China Retail Marketplaces” division.

The appointment marks one of the highest-profile personnel shuffles since China’s largest e-commerce company went public in September.

** OCULAR THERAPEUTIX INC, Monday close $40.25

Ocular said its lead eye drug reduced pain and inflammation in patients following cataract surgery in a late-stage trial. The company said it expects results from a second late-stage study for the drug, OTX-DP, by the end of March. (Compiled by Rohit T.K. in Bengaluru; Edited by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below